May. 20 at 7:26 PM
$AVXL - And yet, here we are at
$2.68 with a drug that clearly works. We have endured massive short positions that played us like a banjo at a southern BBQ. And lets not forget our previous leader and his years of mismanagement. None of us have any clue what's taken place internally and the decisions that were made on any proposed partnerships, or even an outright buyout. Maybe none of that was ever on the table, or maybe it almost happened.
All we do know is, we have a product that works, a strong pipeline of future candidates that may come to fruition, and what appears to be a very knowledgeable leadership team ever to make this work. We shall see in the not so distant future if this will finally succeed in receiving approval. Like a lot of you, we've seen some of these small bio's sit stagnant, then you wake up one day and it's to the moon for years. It happened to me once, and I believe Anavex will be my 2nd.
We Shall See
